News from gerresheimer ag A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

11 Jul, 2019, 07:09 BST Gerresheimer Reports Strong Second Quarter

Revenues up 7.2% on the prior-year quarter to EUR 356.5m Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR...


14 May, 2019, 09:31 BST Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG on May 15, 2019

Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial...


11 Apr, 2019, 07:19 BST Gerresheimer Makes Good Start Into the New Financial Year

Revenues up 6.3% on the prior-year quarter to EUR 308.5m Adjusted EBITDA at EUR 145.9m in first quarter of 2019 (Q1 2018: EUR 52.6m), comprising of...


07 Mar, 2019, 12:00 GMT Gerresheimer Is Investing in a New Plant in Skopje, North Macedonia, for Medical Plastic Systems and Syringes

Gerresheimer AG is to build a new plant in Skopje, Republic of North Macedonia. "As part of our growth strategy, we require additional manufacturing...


14 Feb, 2019, 06:57 GMT Gerresheimer Back on Growth Path and Sets Course for the Future

Revenues at constant exchange rates up 4.3% in the financial year 2018 to EUR 1,406.7m Adjusted EBITDA at constant exchange rates at EUR 307.5m,...


28 Nov, 2018, 09:16 GMT Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG

Dr. Bernd Metzner (48) is to become Chief Financial Officer of Gerresheimer AG, taking up office at the latest on July 1, 2019. Dr. Bernd Metzner has ...


11 Oct, 2018, 07:02 BST Gerresheimer Increases Revenues by 8.8% and Successfully Integrates Sensile Medical

Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m Adjusted EBITDA at constant exchange rates-excluding Sensile...


11 Oct, 2018, 06:43 BST Andreas Schütte Steps Down From Management Board of Gerresheimer AG

Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new...


27 Sep, 2018, 11:04 BST Micro Pump for Parkinson's treatment from Gerresheimer Subsidiary Sensile Medical Receives European CE Declaration of Conformity

A wearable micro pump from Sensile Medical has received EU certification for the European market. A European pharma company has obtained a CE...


06 Sep, 2018, 12:20 BST Dietmar Siemssen Appointed New CEO of Gerresheimer AG

Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018 Previously held position as Stabilus CEO Speaker of the Management Board...


11 Jul, 2018, 22:13 BST Gerresheimer Extends Business Model and Increases Growth Forecast

With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM)...


12 Apr, 2018, 07:10 BST Gerresheimer Raises Earnings per Share in First Quarter Due to US Tax Reform

Revenues at constant exchange rates EUR 299.2m in first quarter of 2018, as expected, stable relative to prior-year period; organic revenue growth...


22 Feb, 2018, 07:34 GMT Gerresheimer Reports Strong Fourth Quarter After Difficult First Nine Months

Fourth-quarter revenues up 4.7%, with organic growth of 6.7%. Slight 2.0% decrease for full year 2017 to EUR 1,348.3m. Revenues at constant exchange...


05 Feb, 2018, 20:35 GMT Dr. Christian Fischer Resigns as CEO of Gerresheimer AG

Dr. Christian Fischer, Chairman of the Management Board of Gerresheimer AG, will leave the Company with immediate effect. Dr. Fischer has asked for...


23 Jan, 2018, 20:57 GMT Gerresheimer Expects Significant Positive Effects from the US Tax Reform in 2018

On December 22, 2017, the US President signed the US tax reform, also known as the Tax Cuts and Jobs Act. The main changes from Gerresheimer's...


08 Jan, 2018, 09:00 GMT Dr. Lukas Burkhardt New Member of the Management Board at Gerresheimer AG

Dr. Lukas Burkhardt (38) has been appointed to the Management Board of Gerresheimer AG effective January 1, 2018. Lukas Burkhardt assumes...


11 Oct, 2017, 07:23 BST Gerresheimer in Q3 2017: Slight Improvement in Adjusted EBITDA Margin

Revenues down from EUR 350.4m in Q3 2016 to EUR 331.5m in Q3 2017; organic decrease of 4.3%. Adjusted EBITDA margin slightly improved to 23.4% (Q3...


31 Aug, 2017, 10:19 BST Dr. Christian Fischer to Succeed Uwe Röhrhoff as CEO of Gerresheimer AG

With effect from September 1, 2017, Dr. Christian Fischer (53) is to assume responsibility as Chief Executive Officer of Gerresheimer AG. He succeeds ...


13 Jul, 2017, 07:35 BST Gerresheimer Expecting Recovery in Second Half Year

Revenues in second quarter of 2017 down 2.2% to EUR 339.5m as expected Adjusted EBITDA margin 22.3%, versus 23.2% in prior-year quarter Slight...


06 Apr, 2017, 07:41 BST Gerresheimer Confirms Guidance Despite Moderate Start to the Year

- Revenues Down 5.4% in First Quarter of 2017 to EUR 302.8m - Adjusted EBITDA Margin at 19.8%, as in Prior Year - EBITDA Leverage Unchanged at 2.6 -...


15 Feb, 2017, 07:30 GMT Gerresheimer Delivers Sustained Profitability Growth in 2016 and Proposes a Dividend Increase of 23.5%

- Proposed dividend of EUR 1.05 per share (2015: EUR 0.85 per share) marks an increase of 23.5% - Revenues up 7.2% in financial year 2016 to EUR...


12 Sep, 2016, 07:13 BST Gerresheimer to Sell Life Science Research Business

Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One Equity ...


07 Jul, 2016, 06:57 BST Gerresheimer Substantially Increases Earnings in Second Quarter

Revenues up 4.0% to EUR 370.5m Adjusted EBITDA rises 17.5% to EUR 84.7m Adjusted EBITDA margin climbs to 22.8% Adjusted earnings per share surpass...


13 Apr, 2016, 06:30 BST Gerresheimer Reports Strong First Quarter

First quarter revenues up 13.4% to EUR 342.3m Adjusted EBITDA grows by 29.6% to EUR 66.0m (Q1 2015: EUR 51.0m) Adjusted earnings per share surpasses...


11 Feb, 2016, 07:33 GMT Gerresheimer Expects Around 9% Growth in 2016

Revenues in financial year 2015 up 6.8% to EUR 1,377.2m Adjusted EBITDA climbs to EUR 277.9m Adjusted earnings per share rise 18.0% to EUR 3.41...